Sorry, this entry is only available in Ukrainian and Russian.
Україна як хаб ліків для ЄС — що заважає реалізації ідеї з точки зору фармвиробників
Вас может заинтересовать:
WEB only
The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications for medicines…
WEB only
The IMA Group strengthens its presence in the pharma and consumer goods sectors On August 1st 2024, IMA Group, through the new established IMA Sarong, completed the closing for the acquisition of the…
